Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2026-03-12 @ 6:25 AM
Study NCT ID:
NCT01320735
Status:
COMPLETED
Last Update Posted:
2015-07-08
First Post:
2011-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-14
First Submit QC Date:
None
Study First Post Date:
2011-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-19
Results First Submit QC Date:
None
Results First Post Date:
2015-07-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-11
Last Update Post Date:
2015-07-08
Last Update Post Date Type:
ESTIMATED